ETX.L Share News (ETX)
ETX Share
ETX Share
ETX Share
ETX Share
ETX
ETX Share
ETX Broker
ETX Directors
ETX Financial
ETX
ETX Short
ETXFri, 04th Jul 2014 08:59
LONDON (Alliance News) - e-Therapeutics PLC Friday said Finance Director Steve Medlicott bought 100,000 shares at a price of 29 pence per share Thursday. The shares represent his only holding in the company.
Shares in the research and development company were down 5.3% at 27.00p Friday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus
Read more(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.
Read more(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.
Read moreAIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins
Read moree-Therapeutics raises GBP23 million to expand capability and pipeline
Read moreIN BRIEF: e-Therapeutics to raise GBP20 million to expand capability
Read moreTRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity
Read moreAIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise
Read moreUK earnings, trading statements calendar - next 7 days
Read moreAIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale
Read moree-Therapeutics gets two payments from Galapagos under collaboration
Read more(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.
Read moreEXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist
Read more